2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Video Player is loading.
10 seconds
Playback speed
ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malignant Pleural Effusion Caused by Mesothelioma and Advanced Tumors"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Dean Fennell
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Dean Fennell
Comments 0
Login to view comments.
Click here to Login
